Acne Vulgaris Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 69 pages | ID: A0928B97C8DEEN
Market Monitor Global

Abstracts

Acne vulgaris is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high number of oil glands, including the face, upper part of the chest, and back. The resulting appearance can lead to anxiety, reduced self-esteem, and, in extreme cases, depression or thoughts of suicide.

This report contains market size and forecasts of Acne Vulgaris Drug in Global, including the following market information:

Global Acne Vulgaris Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Acne Vulgaris Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

OTC Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Acne Vulgaris Drug include Galderma, Bausch Health, Teva, GlaxoSmithKline, Mylan, Almirall, Sun Pharma, Mayne Pharma and Lion, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acne Vulgaris Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Acne Vulgaris Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Acne Vulgaris Drug Market Segment Percentages, by Type, 2021 (%)

• OTC
• Prescription Medicine

Global Acne Vulgaris Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Acne Vulgaris Drug Market Segment Percentages, by Application, 2021 (%)

• Topical
• Oral

Global Acne Vulgaris Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Acne Vulgaris Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Acne Vulgaris Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Acne Vulgaris Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Galderma
• Bausch Health
• Teva
• GlaxoSmithKline
• Mylan
• Almirall
• Sun Pharma
• Mayne Pharma
• Lion
• HUAPONT
• Sine Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Acne Vulgaris Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Acne Vulgaris Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ACNE VULGARIS DRUG OVERALL MARKET SIZE

2.1 Global Acne Vulgaris Drug Market Size: 2021 VS 2028
2.2 Global Acne Vulgaris Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Acne Vulgaris Drug Players in Global Market
3.2 Top Global Acne Vulgaris Drug Companies Ranked by Revenue
3.3 Global Acne Vulgaris Drug Revenue by Companies
3.4 Top 3 and Top 5 Acne Vulgaris Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Acne Vulgaris Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acne Vulgaris Drug Players in Global Market
  3.6.1 List of Global Tier 1 Acne Vulgaris Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Acne Vulgaris Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Acne Vulgaris Drug Market Size Markets, 2021 & 2028
  4.1.2 OTC
  4.1.3 Prescription Medicine
4.2 By Type - Global Acne Vulgaris Drug Revenue & Forecasts
  4.2.1 By Type - Global Acne Vulgaris Drug Revenue, 2017-2022
  4.2.2 By Type - Global Acne Vulgaris Drug Revenue, 2023-2028
  4.2.3 By Type - Global Acne Vulgaris Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Acne Vulgaris Drug Market Size, 2021 & 2028
  5.1.2 Topical
  5.1.3 Oral
5.2 By Application - Global Acne Vulgaris Drug Revenue & Forecasts
  5.2.1 By Application - Global Acne Vulgaris Drug Revenue, 2017-2022
  5.2.2 By Application - Global Acne Vulgaris Drug Revenue, 2023-2028
  5.2.3 By Application - Global Acne Vulgaris Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Acne Vulgaris Drug Market Size, 2021 & 2028
6.2 By Region - Global Acne Vulgaris Drug Revenue & Forecasts
  6.2.1 By Region - Global Acne Vulgaris Drug Revenue, 2017-2022
  6.2.2 By Region - Global Acne Vulgaris Drug Revenue, 2023-2028
  6.2.3 By Region - Global Acne Vulgaris Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Acne Vulgaris Drug Revenue, 2017-2028
  6.3.2 US Acne Vulgaris Drug Market Size, 2017-2028
  6.3.3 Canada Acne Vulgaris Drug Market Size, 2017-2028
  6.3.4 Mexico Acne Vulgaris Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Acne Vulgaris Drug Revenue, 2017-2028
  6.4.2 Germany Acne Vulgaris Drug Market Size, 2017-2028
  6.4.3 France Acne Vulgaris Drug Market Size, 2017-2028
  6.4.4 U.K. Acne Vulgaris Drug Market Size, 2017-2028
  6.4.5 Italy Acne Vulgaris Drug Market Size, 2017-2028
  6.4.6 Russia Acne Vulgaris Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Acne Vulgaris Drug Market Size, 2017-2028
  6.4.8 Benelux Acne Vulgaris Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Acne Vulgaris Drug Revenue, 2017-2028
  6.5.2 China Acne Vulgaris Drug Market Size, 2017-2028
  6.5.3 Japan Acne Vulgaris Drug Market Size, 2017-2028
  6.5.4 South Korea Acne Vulgaris Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Acne Vulgaris Drug Market Size, 2017-2028
  6.5.6 India Acne Vulgaris Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Acne Vulgaris Drug Revenue, 2017-2028
  6.6.2 Brazil Acne Vulgaris Drug Market Size, 2017-2028
  6.6.3 Argentina Acne Vulgaris Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Acne Vulgaris Drug Revenue, 2017-2028
  6.7.2 Turkey Acne Vulgaris Drug Market Size, 2017-2028
  6.7.3 Israel Acne Vulgaris Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Acne Vulgaris Drug Market Size, 2017-2028
  6.7.5 UAE Acne Vulgaris Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Galderma
  7.1.1 Galderma Corporate Summary
  7.1.2 Galderma Business Overview
  7.1.3 Galderma Acne Vulgaris Drug Major Product Offerings
  7.1.4 Galderma Acne Vulgaris Drug Revenue in Global Market (2017-2022)
  7.1.5 Galderma Key News
7.2 Bausch Health
  7.2.1 Bausch Health Corporate Summary
  7.2.2 Bausch Health Business Overview
  7.2.3 Bausch Health Acne Vulgaris Drug Major Product Offerings
  7.2.4 Bausch Health Acne Vulgaris Drug Revenue in Global Market (2017-2022)
  7.2.5 Bausch Health Key News
7.3 Teva
  7.3.1 Teva Corporate Summary
  7.3.2 Teva Business Overview
  7.3.3 Teva Acne Vulgaris Drug Major Product Offerings
  7.3.4 Teva Acne Vulgaris Drug Revenue in Global Market (2017-2022)
  7.3.5 Teva Key News
7.4 GlaxoSmithKline
  7.4.1 GlaxoSmithKline Corporate Summary
  7.4.2 GlaxoSmithKline Business Overview
  7.4.3 GlaxoSmithKline Acne Vulgaris Drug Major Product Offerings
  7.4.4 GlaxoSmithKline Acne Vulgaris Drug Revenue in Global Market (2017-2022)
  7.4.5 GlaxoSmithKline Key News
7.5 Mylan
  7.5.1 Mylan Corporate Summary
  7.5.2 Mylan Business Overview
  7.5.3 Mylan Acne Vulgaris Drug Major Product Offerings
  7.5.4 Mylan Acne Vulgaris Drug Revenue in Global Market (2017-2022)
  7.5.5 Mylan Key News
7.6 Almirall
  7.6.1 Almirall Corporate Summary
  7.6.2 Almirall Business Overview
  7.6.3 Almirall Acne Vulgaris Drug Major Product Offerings
  7.6.4 Almirall Acne Vulgaris Drug Revenue in Global Market (2017-2022)
  7.6.5 Almirall Key News
7.7 Sun Pharma
  7.7.1 Sun Pharma Corporate Summary
  7.7.2 Sun Pharma Business Overview
  7.7.3 Sun Pharma Acne Vulgaris Drug Major Product Offerings
  7.7.4 Sun Pharma Acne Vulgaris Drug Revenue in Global Market (2017-2022)
  7.7.5 Sun Pharma Key News
7.8 Mayne Pharma
  7.8.1 Mayne Pharma Corporate Summary
  7.8.2 Mayne Pharma Business Overview
  7.8.3 Mayne Pharma Acne Vulgaris Drug Major Product Offerings
  7.8.4 Mayne Pharma Acne Vulgaris Drug Revenue in Global Market (2017-2022)
  7.8.5 Mayne Pharma Key News
7.9 Lion
  7.9.1 Lion Corporate Summary
  7.9.2 Lion Business Overview
  7.9.3 Lion Acne Vulgaris Drug Major Product Offerings
  7.9.4 Lion Acne Vulgaris Drug Revenue in Global Market (2017-2022)
  7.9.5 Lion Key News
7.10 HUAPONT
  7.10.1 HUAPONT Corporate Summary
  7.10.2 HUAPONT Business Overview
  7.10.3 HUAPONT Acne Vulgaris Drug Major Product Offerings
  7.10.4 HUAPONT Acne Vulgaris Drug Revenue in Global Market (2017-2022)
  7.10.5 HUAPONT Key News
7.11 Sine Pharma
  7.11.1 Sine Pharma Corporate Summary
  7.11.2 Sine Pharma Business Overview
  7.11.3 Sine Pharma Acne Vulgaris Drug Major Product Offerings
  7.11.4 Sine Pharma Acne Vulgaris Drug Revenue in Global Market (2017-2022)
  7.11.5 Sine Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Acne Vulgaris Drug Market Opportunities & Trends in Global Market
Table 2. Acne Vulgaris Drug Market Drivers in Global Market
Table 3. Acne Vulgaris Drug Market Restraints in Global Market
Table 4. Key Players of Acne Vulgaris Drug in Global Market
Table 5. Top Acne Vulgaris Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Acne Vulgaris Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Acne Vulgaris Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Acne Vulgaris Drug Product Type
Table 9. List of Global Tier 1 Acne Vulgaris Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acne Vulgaris Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Acne Vulgaris Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Acne Vulgaris Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Acne Vulgaris Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Acne Vulgaris Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Acne Vulgaris Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Acne Vulgaris Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Acne Vulgaris Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Acne Vulgaris Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Acne Vulgaris Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Acne Vulgaris Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Acne Vulgaris Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Acne Vulgaris Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Acne Vulgaris Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Acne Vulgaris Drug Revenue, (US$, Mn), 2023-2028
Table 30. Galderma Corporate Summary
Table 31. Galderma Acne Vulgaris Drug Product Offerings
Table 32. Galderma Acne Vulgaris Drug Revenue (US$, Mn), (2017-2022)
Table 33. Bausch Health Corporate Summary
Table 34. Bausch Health Acne Vulgaris Drug Product Offerings
Table 35. Bausch Health Acne Vulgaris Drug Revenue (US$, Mn), (2017-2022)
Table 36. Teva Corporate Summary
Table 37. Teva Acne Vulgaris Drug Product Offerings
Table 38. Teva Acne Vulgaris Drug Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Acne Vulgaris Drug Product Offerings
Table 41. GlaxoSmithKline Acne Vulgaris Drug Revenue (US$, Mn), (2017-2022)
Table 42. Mylan Corporate Summary
Table 43. Mylan Acne Vulgaris Drug Product Offerings
Table 44. Mylan Acne Vulgaris Drug Revenue (US$, Mn), (2017-2022)
Table 45. Almirall Corporate Summary
Table 46. Almirall Acne Vulgaris Drug Product Offerings
Table 47. Almirall Acne Vulgaris Drug Revenue (US$, Mn), (2017-2022)
Table 48. Sun Pharma Corporate Summary
Table 49. Sun Pharma Acne Vulgaris Drug Product Offerings
Table 50. Sun Pharma Acne Vulgaris Drug Revenue (US$, Mn), (2017-2022)
Table 51. Mayne Pharma Corporate Summary
Table 52. Mayne Pharma Acne Vulgaris Drug Product Offerings
Table 53. Mayne Pharma Acne Vulgaris Drug Revenue (US$, Mn), (2017-2022)
Table 54. Lion Corporate Summary
Table 55. Lion Acne Vulgaris Drug Product Offerings
Table 56. Lion Acne Vulgaris Drug Revenue (US$, Mn), (2017-2022)
Table 57. HUAPONT Corporate Summary
Table 58. HUAPONT Acne Vulgaris Drug Product Offerings
Table 59. HUAPONT Acne Vulgaris Drug Revenue (US$, Mn), (2017-2022)
Table 60. Sine Pharma Corporate Summary
Table 61. Sine Pharma Acne Vulgaris Drug Product Offerings
Table 62. Sine Pharma Acne Vulgaris Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Acne Vulgaris Drug Segment by Type in 2021
Figure 2. Acne Vulgaris Drug Segment by Application in 2021
Figure 3. Global Acne Vulgaris Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Acne Vulgaris Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Acne Vulgaris Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acne Vulgaris Drug Revenue in 2021
Figure 8. By Type - Global Acne Vulgaris Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Acne Vulgaris Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Acne Vulgaris Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Acne Vulgaris Drug Revenue Market Share, 2017-2028
Figure 12. US Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Acne Vulgaris Drug Revenue Market Share, 2017-2028
Figure 16. Germany Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Acne Vulgaris Drug Revenue Market Share, 2017-2028
Figure 24. China Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Acne Vulgaris Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Acne Vulgaris Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Acne Vulgaris Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Galderma Acne Vulgaris Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bausch Health Acne Vulgaris Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teva Acne Vulgaris Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Acne Vulgaris Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Mylan Acne Vulgaris Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Almirall Acne Vulgaris Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sun Pharma Acne Vulgaris Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Mayne Pharma Acne Vulgaris Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Lion Acne Vulgaris Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. HUAPONT Acne Vulgaris Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sine Pharma Acne Vulgaris Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)